Valuation: DocMorris AG

Market Cap 521M 646M 565M 480M 905M 62.24B 926M 6.23B 2.45B 30.48B 2.43B 2.37B 105B P/E 2026 *
-6.71x
P/E 2027 * -12.7x
Enterprise Value 722M 896M 783M 666M 1.26B 86.27B 1.28B 8.63B 3.4B 42.25B 3.36B 3.29B 145B EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.55x
Free-Float
66.58%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 2022-04-27
Director of Finance/CFO 56 2024-09-30
Chief Tech/Sci/R&D Officer - 2024-10-31
Director TitleAgeSince
Chairman 68 2022-04-27
Director/Board Member 53 2019-05-22
Director/Board Member 56 2020-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 646M
-5.05%-0.21%-20.55%-32.27% 15.14B
-3.17%-3.17%-27.59%-35.26% 6.93B
+2.53%+4.48%-20.75%-1.77% 6.13B
-2.80%+3.58%-11.74%-31.41% 3.73B
-3.53%+5.21%+7.97%-31.30% 3.12B
+2.36%+1.93%-37.73%-10.94% 3.25B
-0.11%-1.03%-30.41%-49.47% 3.15B
+0.37%-1.07%+94.71% - 2.57B
+0.98%+3.41%-18.63%-1.07% 2.53B
Average -0.84%+1.09%-7.19%-24.19% 5.17B
Weighted average by Cap. -1.98%+0.63%-14.42%-26.20%

Financials

2026 *2027 *
Net sales 1.23B 1.52B 1.33B 1.13B 2.13B 146B 2.18B 14.64B 5.76B 71.65B 5.7B 5.58B 247B 1.38B 1.71B 1.49B 1.27B 2.39B 164B 2.44B 16.44B 6.47B 80.45B 6.41B 6.27B 277B
Net income -84.01M -104M -91.04M -77.43M -146M -10.03B -149M -1B -395M -4.91B -391M -383M -16.91B -46.25M -57.35M -50.12M -42.63M -80.35M -5.52B -82.13M -553M -217M -2.7B -215M -211M -9.31B
Net Debt 201M 250M 218M 185M 350M 24.03B 357M 2.41B 946M 11.77B 937M 917M 40.52B 237M 293M 256M 218M 411M 28.26B 420M 2.83B 1.11B 13.84B 1.1B 1.08B 47.65B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10.66CHF
Average target price
8.506CHF
Spread / Average Target
-20.20%

Quarterly revenue - Rate of surprise